1H3 — Clearbridge Health Cashflow Statement
0.000.00%
- SG$6.51m
- SG$10.29m
- SG$9.90m
- 15
- 47
- 19
- 13
Annual cashflow statement for Clearbridge Health, fiscal year end - December 31st, SGD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 2.12 | -17.9 | -11.2 | -34.4 | -4.14 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | -2.95 | 13.5 | 10 | 20.8 | 0.379 |
Discontinued Operations | |||||
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -1.32 | -2.73 | -3.5 | 8.66 | 0.43 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 2.61 | -2.99 | -1.98 | -3.57 | -1.93 |
Capital Expenditures | -1.08 | -0.833 | -0.689 | -0.548 | -0.175 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0.177 | 2.01 | -0.394 | 3.62 | 1.36 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.903 | 1.18 | -1.08 | 3.07 | 1.18 |
Financing Cash Flow Items | -0.871 | -0.528 | 2.65 | 0 | 0 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -1.02 | 2.46 | -2.56 | -1.88 | 0.266 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.797 | 0.819 | -5.65 | -2.38 | -0.503 |